NASH Foundation Research Studies
Completed Studies
"A Comprehensive Approach to Manage Concussion in High School and Collegiate Athletes Utilizing IMPACT"
Investigator(s):
Carl C. Berasi, DO
Michael B. Cannone, DO
Timothy P. Duffey, DO
Mark E. Gittins, DO
Francis J. O'Donnell, DO
Scott M. Otis, MD
Michael B. Cannone, DO
Timothy P. Duffey, DO
Mark E. Gittins, DO
Francis J. O'Donnell, DO
Scott M. Otis, MD
Sponsor(s):
"Drug and Non-Drug Treatment of Severe Migraines"
Principal Investigator:
Co-Investigator(s):
Sponsor(s):
National Institute for Health (NIH)
"Home-Based Behavioral Treatment of Migraines in Adolescents: A Pilot Study"
Principal Investigator:
Co-Investigator(s):
Sponsor(s):
National Institute for Health (NIH)
"A Randomized, Double-Blind, Placebo Controlled, Parallel Groups, Outpatient Study to Examine the Safety, Tolerability, and Efficacy of Rizatriptan 5 mg P.O. for the Acute Treatment of Migraine in Adolescents"
Principal Investigator:
Co-Investigator(s):
Sponsor(s):
Merck
"A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Groups, Outpatient Study to Examine the Safety, Tolerability, and Efficacy of Rofecoxib 50 mg and Concomitant Administration of Rofecoxib 50 mg Plus Rizatriptan 10 mg for the Acute Treatment of Migraine"
Principal Investigator:
Co-Investigator(s):
Sponsor(s):
Merck
"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack"
Principal Investigator:
Co-Investigator(s):
Sponsor(s):
GlaxoSmithKline
"Mechanical Testing of Demineralized Femoral/Fibular Rings"
Principal Investigator:
Alan S. Litsky, MD, ScD
Co-Investigator(s):
Sponsor(s):
OSU/OrthoNeuro Foundation
Status:
Ongoing
"Joint Vibration Analysis"
Principal Investigator(s):
"Merck066: A multi-center, double-blind, randomized, parallel, placebo-controlled study to examine the efficacy of Rizatriptan 10 mg tablet administered early during a migraine attack while the pain is mild."
"Pozen: A Double-Blind, Multi-center, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of TreximaTM in the Acute Treatment of Migraine Headaches"
"PROTOCOL SUM30047: "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study to Evaluate the Onset of Efficacy of a New Formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of Migraine"
"NPP30010: A multi-center, randomized, double-blind, placebo-controlled, parallel-group, study to evaluate the safety and efficacy of lamotrigine as add-on treatment in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non-narcotic analgesics."
Primary Investigator:
M.T. Taylor, DO, PhD
Sponsor:
GlaxoSmithKline
"A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirol XR (Extended Release) in Patients with Restless Legs Syndrome."
"A multi-center, double-blind, randomized, parallel-group, placebo controlled study to evaluate the efficacy and tolerability of Rizatriptan 10 mg tablet for the treatment of Menstrual Migraine"
"A randomized, double blind, multi-center, placebo-controlled, crossover study to determine the consistency of TREXIMA (Sumatriptan 85mg/naproxen sodium 500 mg) in the acute treatment of multiple migraines attacks."
Principal Investigators:
Francis J. O'Donnell, DO
M.T. Taylor, DO, PhD
M.T. Taylor, DO, PhD
Sponsor:
Pozen
GlaxoSmithKline
GlaxoSmithKline
"A randomized, double-blind, single migraine attack, placebo-controlled, parallel-group multicenter study to evaluate the efficacy and tolerability of Trexima (sumatriptan succinate/naproxen sodium) tablets vs placebo when administered during the mild pain phase of menstrual migraine in women with dysmenorrhea."
"Memory and Stress Study"
Principal Investigator:
K. Heffner
Sponsor:
Ohio University
"Botox for the Treatment of Occipital Neuralgia"
Primary Investigator:
M.T. Taylor, DO, PhD
Sponsor:
Allergan
Active Studies
"A Prospective, Randomized Clinical Investigation of the Cervitech, Inc. Porous Coated Motion Artificial Disc for Stabilization of the Cervical Spine between C3-C4 and C7-T1."
"Retrospective chart review of INFUSE Bone Graft"
"A Study of Combination Product (sumatriptan succinate and naproxen sodium) in Migraine Subjects who Report Poor Response or Intolerance to Eletriptan)"
"A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients with Restless Legs Syndrome (RLS)"
Primary Investigator:
M.T. Taylor, DO, PhD
Sponsor:
GlaxoSmithKline
"Keppra for the Treatment of Occipital Neuralgia: A Pilot Study"
Primary Investigator:
M.T. Taylor, DO, PhD
Sponsor:
UCB
Pharma
Pharma
"Botulinum Toxin Type A Purified Neurotoxin Complex (BOTOX®) as a Headache Prophylaxis in Migraine Patients."
Primary Investigator:
M.T. Taylor, DO, PhD
Sponsor:
Allergan
"A randomized, double-blind, placebo-controlled study to determine the efficacy of Botulinum Toxin Type A for the Treatment of Plantar Fasciitis"
Primary Investigator:
M.T. Taylor, DO, PhD
Sponsor:
NASH Foundation
Allergan
Allergan
"Project Insight (evaluating co-morbid mood disorders and migraine)"
"Validation of migraine specific assessment measures for adolescents."
Primary Investigators:
Sponsor:
Ohio University
NIH
NIH
"A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and tolerability of TREXIMA (sumatriptan succinate/naproxen sodium) for a single moderate or severe headache in adults diagnosed with probable migraine without aura."
"Discography after lumbar disc arthroplasty"
Primary Investigators: